Onyx Healthcare, Inc.

Onyx Healthcare, Inc.

TTPEX:6569
73.60
TWD
0.00
(0.00%)
4.23EPS
21.73P/E
3.95BMarket Cap

Total Valuation

TWD

As of September 30, 2026, Onyx Healthcare, Inc. carries a market capitalization of 3.95B, placing it among publicly traded companies globally. Its enterprise value stands at 3.83B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.95B
Enterprise Value3.83B

Share Statistics

As of September 30, 2026, Onyx Healthcare, Inc. has 42.82M shares outstanding.

Shares Outstanding42.82M

Valuation Ratios

As of September 30, 2026, Onyx Healthcare, Inc. trades at a trailing price-to-earnings ratio of 21.73. The price-to-sales ratio is 2.56, and the price-to-book ratio stands at 2.08.

PE Ratio21.73
PS Ratio2.56
PB Ratio2.08
P/TBV Ratio2.08
P/FCF Ratio-71.18
P/OCF Ratio-102.32

Enterprise Valuation

As of September 30, 2026, Onyx Healthcare, Inc. trades at an EV/EBITDA multiple of 50.73 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.67 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 72.48 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.83B versus a market cap of 3.95B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.67
EV / EBITDA50.73
EV / EBIT72.48

Financial Position

As of September 30, 2026, Onyx Healthcare, Inc. maintains a current ratio of 3.24, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.05, indicating elevated leverage, while an interest coverage ratio of 11.83 demonstrates strong ability to service its debt obligations.

Current Ratio3.24
Quick Ratio0.96
Debt / Equity8.05
Debt / EBITDA2.03
Interest Coverage11.83

Financial Efficiency

TWD

These figures cover the twelve months ended September 30, 2026. The company generates approximately 9.50M in revenue per employee across its workforce of 151.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee9.50M
Employee Count151.00

Taxes

TWD

Over the twelve months ended September 30, 2026, Onyx Healthcare, Inc. recorded 16.63M in income tax expense. That works out to an effective tax rate of 8.96, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 185.58M, leaving 168.95M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax16.63M
Effective Tax Rate8.96

Stock Price Statistics

TWD

As of the close on November 17, 2026, Onyx Healthcare, Inc.'s stock has declined approximately 31.65% over the past 52 weeks. The 50-day moving average sits at 88.51, while the 200-day moving average is 97.12.

52-Week Price Change-31.65%
50-Day Moving Average88.51
200-Day Moving Average97.12

Income Statement

TWD

Over the twelve months ended September 30, 2026, Onyx Healthcare, Inc. generated 1.43B in revenue and converted that into 168.95M in net income, yielding earnings per share of 4.23. EBITDA reached 75.50M, while operating income came in at 52.10M.

Revenue1.43B
Gross Profit460.65M
Operating Income52.10M
Pretax Income185.58M
Net Income168.95M
EBITDA75.50M
EBIT52.84M
Earnings Per Share (EPS)4.23

Balance Sheet

TWD

As of September 30, 2026, Onyx Healthcare, Inc. holds 271.30M in cash and equivalents against 153.17M in total debt, resulting in a net debt position of -148.17M. Total book value stands at 1.90B, with working capital of 632.95M providing operational flexibility.

Cash & Cash Equivalents271.30M
Total Debt153.17M
Net Debt-148.17M
Equity (Book Value)1.90B
Book Value Per Share44.41
Working Capital632.95M

Cash Flow

TWD

Onyx Healthcare, Inc. produced -35.89M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -15.81M in capital expenditures, free cash flow totaled -51.70M - equivalent to -1.30 per share.

Operating Cash Flow-35.89M
Capital Expenditures-15.81M
Free Cash Flow-51.70M
FCF Per Share-1.30

Margins

Over the twelve months ended September 30, 2026, Onyx Healthcare, Inc. posted a gross margin of 32.11, reflecting its pricing power and cost economics. The operating margin of 3.63 and net profit margin of 11.78 provide insight into operational efficiency.

Gross Margin32.11
Operating Margin3.63
Pretax Margin12.94
Profit Margin11.78
EBITDA Margin5.26

Dividends & Yields

Over the twelve months ended September 30, 2026, Onyx Healthcare, Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -1.40: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.13, meaning Onyx Healthcare, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-2.13
FCF Yield-1.40

Stock Splits

Onyx Healthcare, Inc.'s most recent stock split took place on June 30, 2026 with a 979:991 split ratio.

Last Split Date6/30/2026
Split Ratio979:991

Scores

As of September 30, 2026, Onyx Healthcare, Inc. has an Altman Z-Score of 6.20, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.20